Article
TROP2 methylation and expression in tamoxifen-resistant breast cancer
5 Jul 2018
Abstract excerpt
The DNA methyltransferase 1 inhibitor, 5-Aza-2′-deoxycytidine (5-Aza-dC) is a potential treatment for breast cancer. However, not all breast tumors will respond similarly to treatment with 5-Aza-dC, and little is known regarding the response of hormone-resistant breast cancers to 5-Aza-dC. We demonstrate that 5-Aza-dC-treatment has a stronger effect on an estrogen receptor-negative, Tamoxifen-selected cell line,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
